Skip to content
Screener

Charles River Laboratories CRL Comprehensive Income (Loss), Net of Tax, Attributable to Parent

Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies

Sotera Health logo
Sotera HealthSHC
$36.13M-59.5%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-$46.95M+18.8%
Revvity logo
RevvityRVTY
$48.82M-77.1%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO

Other financials

Income statement

See full
Revenue$1.0B-2.7%
Gross profit$349.0M-3.5%
Operating income$119.9M+19.7%
Net income-$1.5M-103%
EPS (diluted)-$0.03-103%

Balance sheet

See full
Cash & equivalents$240.6M+30.2%
Total debt$3.0B+8.1%
Total equity$2.8B-15.3%
Total assets$7.5B-0.4%

Cash flow

See full
Operating cash flow$179.7M-12.2%
CapEx$31.1M-11.9%
Free cash flow$148.6M-12.2%

Valuation

See full
Market cap$12.77B+74.2%
Enterprise value$15.57B+56.4%
P/S3.2×+1.4×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-6%
FCF margin9.3%-5.1pp

Returns & leverage

See full
Return on equity-7.7%
Debt / equity1.1×+0.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.

The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 9:21 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001100682-26-000118
Line itemThree Months Ended / June 27, 2026Three Months Ended / June 28, 2025Six Months Ended / June 27, 2026Six Months Ended / June 28, 2025
Foreign currency translation adjustment(9,516)121,220(34,696)181,601
Amortization of net loss, settlement losses, and prior service benefit included in total cost for pension and other post-retirement benefit plans8934571,787865
Other comprehensive income (loss), before income taxes(8,623)121,677(32,909)182,466
Less: Income tax expense (benefit) related to items of other comprehensive income(3,122)20,371(7,715)29,919
Comprehensive income (loss), net of income taxes(6,261)153,999(40,756)231,118
Less: Comprehensive income (loss) related to noncontrolling interests, net of income taxes1682,894(225)2,445
Comprehensive income (loss) attributable to Charles River Laboratories International, Inc., net of income taxes$(6,429)$151,105$(40,531)$228,673
See Notes to Unaudited Condensed Consolidated Financial Statements.

Item 1. Financial Statements

FAQ

What is Charles River Laboratories's comprehensive income (loss), net of tax, attributable to parent?
Charles River Laboratories (CRL) reported comprehensive income (loss), net of tax, attributable to parent of -$6.43M in Q2 2026.
How has Charles River Laboratories's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
Charles River Laboratories's comprehensive income (loss), net of tax, attributable to parent decreased by 104.3% year-over-year, from $151.11M to -$6.43M.
What does comprehensive income (loss), net of tax, attributable to parent mean?
This represents the total comprehensive income attributable specifically to the parent company's shareholders, net of tax. It excludes the portion of comprehensive income allocated to noncontrolling interests, focusing on the value generated for the primary entity.

Ask your AI about Charles River Laboratories's comprehensive income (loss), net of tax, attributable to parent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude